XMM-13304-54908
2 vaccinations
1 coded response
16 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 301 / GA
- Registered
- 2021-08-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-28
Registered in v-safe
-
2021-08-28
Dose 1 — Pfizer-BioNTech
- 2021-08-28
-
2021-08-29
Survey response — days 1–6 daily, dose 1MedDRA: Vision blurred — Feeling: Good · Site: Pain · HeadacheFree text: Blurry vision in the eye on the same side as the injectionMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-30
- 2021-08-31
- 2021-09-03
- 2021-09-04
- 2021-09-12
-
2021-09-18
Dose 2 — Pfizer-BioNTech
-
2021-09-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-09-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2021-09-22
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-09-23
- 2021-09-24
- 2021-09-25
- 2021-10-02
- 2021-10-09
- 2021-10-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-28 | Pfizer-BioNTech | No |
| 2 | 2021-09-18 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Blurry vision in the eye on the same side as the injection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Vision blurred | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release